How Kylian Mbappé is building an investment portfolio beyond football

Kylian Mbappé’s latest equity stake in French health insurance startup Alan, is more than a celebrity endorsement packaged as a deal. Taken together with earlier bets on a SailGP team, a Ligue 2 football club, and a digital fantasy platform, it shows a footballer operating with the logic of a diversified investment fund—and a commercial playbook increasingly relevant to our industry.

Why do athletes invest in a health startup insurance?

For the same reasons getting sporting goods brands closer to health monitoring tools.

Mbappé entered Alan’s capital structure directly via Coalition Capital, his personal investment vehicle, joining the company’s March 2026 financing round. The €100 million raise – led by longtime backer Index Ventures – pushed the Paris-based insurtech to a €5 billion valuation. Alan described the contribution as one of the most significant personal investments Mbappé has made to date, though the exact figure was not disclosed publicly.

Mbappé was not the only athlete in the round. Fellow French international Antoine Griezmann of Atlético de Madrid also participated, alongside tech founders Tobias Lütke of Shopify and Mike Katchen of Wealthsimple.

The clustering of footballers and technology entrepreneurs is not completely new. It reflects somehow the dynamics we have seen in the sporting goods industry, more and more intersecting with AI-tech, preventive health, and in wider sense sevices and coaching platform.

According to figures disclosed by the company, Alan generated €785 million in annual recurring revenue (ARR) in 2025, up from €505 million the previous year, and is targeting €1 billion for 2026. It operates across France, Belgium, Spain and Canada, serves approximately 1.1 million users and says it has reached profitability in France, with group-level profitability targeted by 2027.

Its most recent acquisition – preventive health startup Aro – marks the expansion into direct-to-consumer diagnostics, placing Alan increasingly close to the connected fitness and performance management territory that sporting goods brands have been building around.

The portfolio logic of Mbappé Coalition Capital

The Alan deal is the latest in a series of equity positions that reflect a consistent strategy. In March 2025, Coalition Capital acquired a stake in the France SailGP Team, co-investing with hospitality group Accor and French sailing operators. SailGP – now a 12-team, franchise-style global league – marks Mbappé’s entry into commercially scaled, internationally broadcast sport beyond football. The France team is helmed by French Olympian Quentin Delapierre and operated by K-Challenge.

In 2022, Mbappé invested in Sorare, the digital fantasy platform built on licensed athlete cards. Coalition Capital’s acquisition of 80 percent of SM Caen – a Ligue 2 club – for a reported €15–20 million made him a club owner in France.

The common thread is proximity to identity, audience and data. SailGP puts a France flag into a premium international format. Sorare is built on athlete intellectual property and fan monetization. Alan is a daily-use health platform that positions athletes – professional and aspirational – as behavioral guides. SM Caen is a long-term community asset in a home market.

The question brands may not be asking yet

As elite athletes build diversified equity portfolios, the commercial calculus for brands — particularly challengers and newer entrants — is shifting in ways that are not yet widely discussed. The traditional question (“can we sign this athlete?”) is giving way to a more complex one: is an endorsement deal the right structure, or is an equity stake? Neither answer is obvious, and the trade-offs are real on both sides.

An endorsement keeps the relationship transactional and bounded. The brand controls messaging, owns the creative, and can exit if the athlete’s public standing changes. The cost is predictable. For established brands with strong category authority, this is often sufficient: the athlete amplifies what already exists. The risk of giving up equity — dilution, governance complications, the athlete’s own brand agenda taking precedence — outweighs the upside.

For challenger brands, the equation looks different. An athlete-investor brings more than reach: they bring alignment of incentive, co-development potential and, in cases like Mbappé’s involvement with Alan, genuine product integration — step-tracking features, health data, behavioral touchpoints. The athlete has a reason to embed the brand into their own daily life and platform rather than simply appear in its campaign. That depth of involvement is structurally unavailable under an endorsement model.

The downside for the brand is equally structural. An athlete-investor has a seat at the table — or at minimum, a claim on the brand’s trajectory — for as long as the equity relationship holds. If strategic priorities diverge, or if the athlete’s own positioning evolves, the brand cannot simply not renew. And valuation expectations at entry matter: athletes with Coalition Capital-level financial sophistication are not passive minority holders.

The Mbappé portfolio suggests a third variable worth considering: selectivity. The assets Coalition Capital has backed share a common logic — audience proximity, data access, identity fit. Brands that cannot demonstrate those qualities are unlikely to attract serious athlete-investor interest regardless of the terms they offer. The question of endorsement versus investment may therefore resolve itself at the screening stage: athletes, or their investment managers, with genuine portfolio discipline will self-select toward equity in companies that extend their personal brand coherently, and toward endorsement fees from everyone else.

For sporting goods brands building in the health, performance and connected fitness space, the implication is strategic rather than tactical. Athlete equity relationships are becoming a competitive signal — a way of demonstrating that a product or platform is worth owning, not just wearing.